By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus leans bearish, with concerns about geopolitical risks and potential 'compliance contagion' outweighing Alibaba's strong cloud growth. The key risk is the potential erosion of BABA's credibility as a global cloud partner due to unproven allegations and U.S.-China decoupling.
Risk: Erosion of BABA's credibility as a global cloud partner due to unproven allegations and U.S.-China decoupling
Opportunity: Strong domestic cloud growth and potential pivot to non-U.S. platforms
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The artificial intelligence (AI) race between the U.S. and China just got a lot more combustible. Anthropic, one of the United States' most closely watched AI startups, has gone on the offensive against Alibaba (BABA), the Chinese tech giant behind Qwen AI.
Specifically, Anthropic recently filed a formal letter with U.S. senators accusing Alibaba of orchestrating what it called the largest-known effort by a Chinese company to illicitly siphon the capabilities of a leading U.S. AI model. For investors watching BABA stock, this is not a story to ignore.
Before digging into the specifics, investors should understand what distillation means in the context of artificial intelligence.
Building a cutting-edge AI model from scratch costs hundreds of millions of dollars in computing power, research talent, and years of development. Distillation involves training a smaller, cheaper model using outputs generated by an existing, more powerful one. The result is a model that mimics the capabilities of the original at a fraction of the cost.
When done without permission, it is essentially a form of intellectual property theft — and U.S. AI labs are increasingly sounding the alarm about it happening on an industrial scale.
Anthropic previously flagged three separate distillation campaigns traced back to Chinese AI developers DeepSeek, Moonshot, and MiniMax, according to a February company blog post. But what Alibaba allegedly pulled off, the company says, was even bigger.
Now, Anthropic is calling on cloud providers, policymakers, and industry peers to work together to stop the practice.
Anthropic Says Alibaba Used 25,000 Fake Accounts to Target Claude
According to CNBC, which confirmed details of the letter Anthropic sent to Sen. Tim Scott (R-S.C.) and Sen. Elizabeth Warren (D-Mass.) on June 10, operators allegedly tied to Alibaba and its Qwen AI lab carried out nearly 28.8 million exchanges with Claude models. These operators did so using roughly 25,000 fraudulent accounts over a span of about six weeks, from late April through early June 2026.
Bloomberg noted that Anthropic said the campaign zeroed in on Claude's most valuable capabilities, including software engineering and agentic reasoning. These are precisely the functions that are driving the fastest commercial growth in the AI industry right now.
Anthropic described the effort as brazen and illicit, and said it took place after the White House Office of Science and Technology Policy published a memo in April warning that the U.S. would act to stop Chinese companies from exploiting outputs from U.S. AI models.
Alibaba has not commented on the allegations so far, per both CNBC and Bloomberg.
The Political and Market Fallout for Alibaba Stock
Earlier this month, the Pentagon added Alibaba to its list of companies that allegedly support China's armed forces. Alibaba pushed back strongly, saying it has no military affiliation, and it filed a lawsuit last week seeking removal from the list. Now, Alibaba is also facing fresh fire from one of the United States' most prominent AI companies, with Congress already moving to respond.
Bloomberg reported that senators from both parties are working to attach an amendment to must-pass defense legislation that would sanction any Chinese firm found to be improperly accessing U.S. AI model outputs. BABA stock fell almost 5% on June 25 and is down by more than 9% for the past five days.
Meanwhile, Alibaba's AI business has been growing fast. During the company's fiscal fourth-quarter 2026 earnings call, CEO Eddie Wu said the cloud unit grew external revenue by 40% year-over-year (YOY), with AI-related product revenue now accounting for 30% of that total. The company projects AI-related model and application services will hit an annualized revenue run rate of RMB 30 billion ($4.3 billion) by year-end.
That momentum makes the accusations of distillation even more significant. If U.S. lawmakers push through new sanctions or restrictions targeting Chinese AI firms, Alibaba's ability to access U.S. cloud infrastructure and enterprise customers could take a real hit.
Anthropic, for its part, is calling for stronger export controls on advanced AI chips, clearer antitrust rules to allow U.S. companies to share information about distillation attempts, and financial penalties for firms caught stealing model outputs.
The company put it plainly in its letter: Failing to act risks letting China close the gap on the U.S. in artificial intelligence, with consequences for national security.
Is BABA Stock Undervalued?
Analysts tracking BABA stock forecast revenue to increase from $138.2 billion in fiscal 2025 to $205.6 billion in fiscal 2029. In this period, adjusted earnings are projected to expand from $9.08 per share to $11.63 per share. If BABA stock is priced at 15 times forward earnings, it could surge more than 70% within the next few years.
Out of the 26 analysts covering BABA stock, 21 recommend a "Strong Buy" rating, one recommends a "Moderate Buy," and four recommend a "Hold" rating. The average Alibaba stock price target is $184.09, which represents 94% potential upside from current levels.
On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com
Four leading AI models discuss this article
"The distillation allegations provide the necessary political cover for the U.S. to impose terminal restrictions on BABA's access to Western AI ecosystems, rendering current valuation models based on historical growth rates obsolete."
The market is ignoring the structural shift from 'value trap' to 'geopolitical pariah.' While BABA trades at a depressed ~8x forward P/E, this valuation reflects a permanent risk premium due to U.S.-China decoupling. Anthropic’s allegations aren't just about IP; they provide the legislative 'smoking gun' for the U.S. to restrict BABA's access to critical cloud infrastructure and hardware. Even if the revenue growth in the cloud unit is impressive (40% YOY), those figures are vulnerable if the U.S. mandates a total 'de-platforming' of Chinese firms from Western model APIs. Investors banking on a 15x multiple expansion are betting on a geopolitical thaw that is currently nowhere in sight.
Alibaba’s Qwen models have already demonstrated independent state-of-the-art performance on benchmarks like MMLU, suggesting that even if distillation occurred, it may be a marginal contributor to their actual R&D success.
"The distillation accusation is serious but unverified; even if proven, sanctions would likely target chip supply and model access rather than Alibaba's broader cloud business, limiting downside to 10-15% unless Congress moves faster than historical precedent suggests."
The article conflates two separate risks: the distillation accusation (unverified, no Alibaba response) and existing Pentagon sanctions concerns. The distillation claim, if true, is serious IP theft—but Anthropic's letter lacks independent corroboration, and 'fake accounts' could be legitimate users behind VPNs or shared infrastructure. More critically: even if sanctions pass, they'd likely target chip exports or model access, not Alibaba's cloud revenue ($40B+ annually). The article assumes distillation directly threatens BABA's business, but Qwen's growth (30% of cloud revenue) could reflect genuine R&D, not stolen capabilities. Analyst consensus (21 of 26 'Strong Buy') already prices in geopolitical risk; the 9% drop is modest for a company facing potential U.S. restrictions.
If the distillation campaign is real and Congress acts decisively—banning Chinese access to U.S. model APIs or restricting enterprise customers from using Alibaba infrastructure—BABA's cloud margins compress sharply, and the $4.3B AI revenue target becomes unachievable, justifying a 20-30% re-rating downward.
"Unverified distillation claims add volatility but lack the concrete enforcement needed to derail BABA's domestic AI momentum."
The article frames Anthropic's June 10 letter as a major new risk for BABA, citing 25,000 fake accounts and 28.8 million Claude queries. Yet the claims remain unproven allegations with no enforcement action, no Alibaba response, and no direct link to Qwen revenue. BABA's cloud AI run-rate already targets RMB 30 billion annualized by year-end, driven by domestic customers unlikely to care about U.S. export controls. The 5% drop on June 25 and 9% five-day decline price in headline risk rather than quantified revenue loss. Strong analyst targets at $184 reflect this disconnect between political noise and earnings trajectory.
If bipartisan sanctions attach to the defense bill as described, they could block U.S. chip access and enterprise deals, cutting the 40% cloud growth far more than the article's valuation math assumes.
"Despite the headline risk, the key bear thesis is that policy actions and possible sanctions could materially restrict Alibaba's access to U.S. cloud infrastructure, creating a bigger, longer-lasting headwind than the alleged distillation incident."
The piece injects geopolitics into a stock story, implying imminent sanctions risk from distillation allegations. The practical hit to Alibaba, however, depends on policy actions and actual revenue exposure, which the article doesn't quantify. The 28.8 million exchanges and 25,000 accounts signal activity but not economic impact; Alibaba's cloud business posted 40% YoY growth and AI-related revenue is already ~30% of cloud revenue, suggesting an operating moat that could cushion shocks. A broad U.S.-China tech decoupling is plausible, but policy implementation lags and Alibaba can pivot to non-U.S. platforms. The risk is real, but the stock reaction may overstate near-term impact.
Counter: If policymakers decide to sanction or restrict access broadly, the fallout could be material for BABA's cloud and enterprise customers, making this more than headline risk. Also, markets punished BABA on June 25, indicating a sensitivity to this theme that could persist.
"Western enterprise clients will exit BABA's cloud due to compliance fears, regardless of whether the distillation claims are technically proven."
Claude and Grok are underestimating the 'compliance contagion' risk. Even if distillation allegations remain unproven, major Western enterprise clients—the highest-margin segment for BABA’s international cloud—will likely preemptively offboard to avoid potential regulatory entanglement or IP liability. This isn't just about chip sanctions; it’s about the erosion of BABA’s credibility as a global cloud partner. When Fortune 500 firms fear 'tainted' infrastructure, the 40% growth rate in cloud revenue will evaporate regardless of Qwen’s technical merit.
"Compliance contagion requires proof of actual customer flight; the policy mechanism matters more than the allegation."
Gemini's 'compliance contagion' thesis assumes Fortune 500 clients will flee preemptively, but that's speculative without evidence of actual customer defection. More critically: BABA's $40B+ cloud revenue is *domestic-focused*. International enterprise is a smaller slice. If sanctions target chip access or U.S. model APIs, domestic customers remain insulated. The real test is whether U.S. policy actually restricts *access to* Alibaba infrastructure (hard to enforce) versus restricting *exports to* China (easier). We're conflating two different policy regimes.
"Domestic revenue isn't insulated from U.S. compliance contagion via global supply chain integrations."
Claude overlooks that even domestic Chinese customers increasingly integrate with global supply chains, where U.S. compliance rules could force indirect de-risking from Alibaba Cloud. The distinction between export restrictions and infrastructure access enforcement ignores how secondary sanctions or customer due diligence requirements often blur these lines, amplifying revenue pressure beyond direct policy hits.
"Near-term risk is regulatory drag, not mass client defections, which could slow cross-border AI revenue and compress margins even if domestic cloud remains robust."
Gemini's 'compliance contagion' is a useful worry, but the bigger, underappreciated risk is regulatory drag rather than immediate client defections. Even without mass offboarding, procurement cycles tighten, data localization and due-diligence costs rise, and international AI deals slow. A policy overhang could cap Alibaba Cloud's cross-border revenue growth and compress margins long before Fortune 500s yank contracts, meaning the bear case is a slower, not zero, growth path.
The panel consensus leans bearish, with concerns about geopolitical risks and potential 'compliance contagion' outweighing Alibaba's strong cloud growth. The key risk is the potential erosion of BABA's credibility as a global cloud partner due to unproven allegations and U.S.-China decoupling.
Strong domestic cloud growth and potential pivot to non-U.S. platforms
Erosion of BABA's credibility as a global cloud partner due to unproven allegations and U.S.-China decoupling